MBCT for Psoriasis Patients With Anxiety and Depression
NCT ID: NCT05010044
Last Updated: 2021-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2021-08-31
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study of Mindfulness Based Cognitive Therapy and Obsessive-Compulsive Disorder
NCT03179839
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
NCT02217995
Effect of SC-ICBT for Adults With OCD:A Three-Arm Randomized Controlled Trial
NCT05528224
Treatment of Hypochondriasis With CBT and/or SSRI
NCT00339079
Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder
NCT00632229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants received MBCT once a week for 8 weeks
Participants received MBCT once a week for 8 weeks. At the same time, the drug therapy for psoriasis was used .
mindfulness-based cognitive therapy (MBCT)
Mindfulness- Based Cognitive Therapy (MBCT) It involves practicing to be present 'in the moment' and an attitude of non- judgmental acceptance with the aim to maintain awareness, disengaging oneself from strong attachment and thereby developing a greater sense of emotional balance and well-being.
Antipsoriatic treatment
The routine drug therapy for psoriasis.
Active comparator
Only the drug therapy for psoriasis was used .
Antipsoriatic treatment
The routine drug therapy for psoriasis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mindfulness-based cognitive therapy (MBCT)
Mindfulness- Based Cognitive Therapy (MBCT) It involves practicing to be present 'in the moment' and an attitude of non- judgmental acceptance with the aim to maintain awareness, disengaging oneself from strong attachment and thereby developing a greater sense of emotional balance and well-being.
Antipsoriatic treatment
The routine drug therapy for psoriasis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fulfilled the Classification Criteria for Psoriasis
* the score of the SDS \> 50 and / or SAS \>50
* Participant has normal or corrected to normal vision and hearing
* Participant is willing and able to give informed consent for participation in the study.
Exclusion Criteria
* severe systemic diseases
* patients with severe mental illness or taking psychotic drugs
* Pregnancy
* No access to the internet
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Zhou, professor
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital Xi'an Jiaotong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XJTU1AF-CRF-2019-027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.